SEC Form 4 · accession 0001181431-15-001523

DAVITA INC. · DVA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — COO, Kidney Care

Period of report

Jan 23, 2015

Accepted (ET)

Jan 27, 2015 · 7:52 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000927066

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F3	Jan 23, 2015	M	40,000	$34.515	A	40,394	D
Common Stock	Jan 23, 2015	F	18,131	$76.15	D	22,263	D
Common Stock^F2	Jan 23, 2015	S	21,869	$76.0542	D	394	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Appreciation Rights^F4	$34.515	Jan 23, 2015	M	40,000	D	Sep 30, 2011	Sep 30, 2015	Common Stock	40,000	0	D

F1The sales reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2014.
F2Represents the weighted average sale price of $76.0542. The range of prices for the sale of these shares was $75.76 - $76.26, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F3Includes 394 shares that were purchased through the 2014 Employee Stock Purchase Program (ESPP)on 12/31/2014.
F4Stock Appreciation Rights, granted on 9/30/2010, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, then 6.25% every three months thereafter.